https://www.cochrane.org/zh-hant/evidence/CD002750_calcium-antagonists-add-therapy-drug-resistant-epilepsy
Calcium antagonists as an add-on therapy for drug-resistant epilepsy | Cochrane
add on therapydrug resistant epilepsy
https://www.cochrane.org/evidence/CD009503_drugs-used-add-therapy-heart-procedure-following-heart-attack
Drugs used as add-on therapy to heart procedure following heart attack | Cochrane
add on therapy
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1239152/full
Frontiers | Cenobamate as add-on therapy for drug resistant epilepsies: effectiveness, drug to drug...
Background: Cenobamate (CNB) is an anti-seizure medication (ASM) approved in 2021 in Europe for adjunctive treatment of focal-onset seizures in adults who we...
add on therapy
https://www.elsevier.es/en-revista-annals-hepatology-16-articulo-randomised-controlled-trial-effect-metformin-S1665268122000874
Randomised controlled trial: effect of metformin add-on therapy on functional cure in...
Introduction and ObjectivesHepatitis B surface antigen (HBsAg) clearance, indicating
randomised controlled trial
https://www.cochrane.org/evidence/CD008841_lacosamide-add-therapy-focal-epilepsy
Lacosamide add-on therapy for focal epilepsy | Cochrane
add on therapyfocal epilepsylacosamidecochrane